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Phosphotyrosine (pTyr) signaling, which plays a central role in cell–cell and cell–environment interactions, has been
considered to be an evolutionary innovation in multicellular metazoans. However, neither the emergence nor the evolution of the human pTyr signaling system is currently understood. Tyrosine kinase (TK) circuits, each of which consists
of a TK writer, a kinase substrate, and a related reader, such as Src homology (SH) 2 domains and pTyr-binding (PTB)
domains, comprise the core machinery of the pTyr signaling network. In this study, we analyzed the evolutionary trajectories of 583 literature-derived and 50,000 computationally predicted human TK circuits in 19 representative
eukaryotic species and assigned their evolutionary origins. We found that human TK circuits for intracellular pTyr
signaling originated largely from primitive organisms, whereas the inter- or extracellular signaling circuits experienced
significant expansion in the bilaterian lineage through the ‘‘back-wiring’’ of newly evolved kinases to primitive substrates
and SH2/PTB domains. Conversely, the TK circuits that are involved in tissue-specific signaling evolved mainly in vertebrates by the back-wiring of vertebrate substrates to primitive kinases and SH2/PTB domains. Importantly, we found
that cancer signaling preferentially employs the pTyr sites, which are linked to more TK circuits. Our work provides
insights into the evolutionary paths of the human pTyr signaling circuits and suggests the use of a network approach for
cancer intervention through the targeting of key pTyr sites and their associated signaling hubs in the network.
[Supplemental material is available for this article.]
An important feature that distinguishes multicellular metazoans
from unicellular organisms is that the former possess elaborate
regulatory and signaling systems for divergent functions (Putnam
et al. 2007; King et al. 2008; Manning et al. 2008; Pincus et al. 2008;
Lim and Pawson 2010). It has been suggested that the development of complex regulatory systems, such as molecular networks that are mediated by tyrosine phosphorylation, plays an
important role in the appearance of multicellularity and the coordination of complex morphogenetic events in eumetazoans
(Weiss and Littman 1994; Tan et al. 2009b). Therefore, understanding of the evolutionary paths of cellular regulatory networks
is important for the evolution of animal complexity and for the
achievement of a system-level understanding of human development and the pathophysiology of complex diseases (Boran and
Iyengar 2010).
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Tyrosine-kinase-mediated phosphotyrosine (pTyr) signaling has
been used as a model to promote the understanding of the evolution
of signaling networks and cell–cell communications in multicellular
animals (King et al. 2003; Nichols et al. 2006; Grimson et al. 2008).
The core machinery, or the tyrosine kinase (TK) circuit in pTyr signaling, consists of a TK that functions as the ‘‘writer’’ to phosphorylate a Tyr residue in a protein substrate, an SH2/pTyr-binding (PTB)
domain that acts as a ‘‘reader’’ to recognize the modification, and
a protein tyrosine phosphatase (PTP) that plays the role of an ‘‘eraser’’
to terminate the kinase signal (Pincus et al. 2008). Previous studies
have focused on the evolution of individual components of the pTyr
signaling circuit, but it is clear that the evolution of these components is highly dependent on the other components and their formation of functional circuits, which are further integrated into a
more complex pTyr signaling network (Nichols et al. 2006; King et al.
2008; Pincus et al. 2008; Tan et al. 2009b; Gough and Foley 2010).
Therefore, it is important to understand how the elaborate cell–cell
communication and tissue-specific signaling mechanisms that are
found in the human pTyr signaling network functionally evolved
from the TK circuits. The examination of the TK circuit as a functional unit may yield insights that are unattainable by studying the
individual components separately.
To our knowledge, no study has previously directly addressed
how human pTyr signaling circuits and networks evolved from premetazoans and unicellular metazoans. In this study, we investigated
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Human phosphotyrosine signaling network evolution
the evolution of the human pTyr signaling system by analyzing the
evolution of the human TK circuits. We classified the TK circuits into
discrete signaling routes that are associated with intracellular, inter-/
extracellular, and tissue-specific signaling and then examined the
path of human TK circuit evolution by comparing the human TK
circuits to orthologous circuits from 19 representative organisms and
investigated (1) in which organisms the human TK circuit components originated and (2) which evolutionary paths were preferentially used for the formation of circuits that are responsible for intracellular, inter-/extracellular, and tissue-specific pTyr signaling.
These 19 organisms are either well-known model organisms or key
species in evolution. For example, Monosiga brevicollis, which is the
closest-known relative to metazoans, is an organism that can provide
clues regarding the genesis of the animal kingdom, while Nematostella vectensis, which is the simplest, most primitive animal with
a tissue grade of organization, is an emerging model in which to
study the evolution of the ancient cell–cell communication system.
These analyses revealed key steps and distinct trajectories in the
evolution of the different human pTyr signaling routes. We also show
that cancer signaling preferably exploited promiscuous pTyr sites on
multifunctional substrates.

strate) were grouped by protein families based on common binding properties and/or biological functions (e.g., CRK and CRKL are
placed in the same group; see Methods) (Huang et al. 2008).
Moreover, the pTyr sites from different members of the same protein
family that are conserved (based on multiple sequence alignment
by MAFFT) (Katoh et al. 2005) were treated as a single pTyr site to
assemble the corresponding TK circuit.
For each human TK circuit, we identified the orthologs of the
circuit components in 19 selected species (Wall et al. 2003; Elango
et al. 2009; Cherry 2010). Because abundant information for the
TK circuits is available in humans and yet this information is much
sparser in other organisms (Tan et al. 2009a), we started from a
human TK circuit and back-predicted the orthologous circuit in
a target species using the Roundup database (see Methods). The
selected 19 species are: Saccharomyces cerevisiae, M. brevicollis, N.
vectensis, Caenorhabditis elegans, Drosophila melanogaster, Bos taurus,
Canis familiaris, Danio rerio, Gallus gallus, Gasterosteus aculeatus,
Macaca mulatta, Monodelphis domestica, Mus musculus, Ornithorhynchus anatinus, Oryzias latipes, Pan troglodytes, Rattus norvegicus,
Takigufu rubripes, Xenopus tropicalis, and Homo sapiens (Fig. 1B).

Results
Assembly of the human TK circuit
data sets and the identification
of orthologous circuits
in model organisms
The simplified TK circuit that was analyzed in this study is composed of a TK,
a substrate containing an experimentally
verified pTyr site, and a protein containing an SH2/PTB domain (Fig. 1A). Because
of the generally broad specificity of a PTP
(Moorhead et al. 2009) and the paucity
of information on specific PTP–substrate
interactions, we excluded PTPs from the
TK circuits, even though they are an integral part of the tyrosine kinase signaling
system (Pincus et al. 2008). We also excluded dual-specificity kinases (Lindberg
et al. 1992) because they can phosphorylate both tyrosine and serine/threonine
residues, which makes the signaling outcome uncertain. Moreover, no reliable
algorithm is currently available for the prediction of PTP–substrate or dual-specific
kinase–substrate relationships.
To analyze the human TK circuits, we
assembled two data sets (see Methods): (1)
a curated human TK circuit data set (583
circuits) (Supplemental Data File 1), and
(2) a computationally predicted data set
(;50,000 circuits) in which the pTyr
(and, therefore, the substrate) is experimentally verified but the corresponding
kinase and SH2/PTB domain are predicted
using existing algorithms (Supplemental
Data File 2).
To simplify the analysis, the circuit
components (i.e., TK, SH2/PTB, and sub-

Figure 1. A schematic drawing of the tyrosine kinase (TK) signaling circuit and grouping of species
used for the analysis of the human TK circuit evolution. (A) A simplified TK circuit that comprises a kinase
that functions as the ‘‘writer,’’ a substrate that contains a specific tyrosine (Tyr) site for phosphorylation,
and an SH2 or PTB domain-containing protein that functions as the reader of the phosphorylated Tyr
(pTyr). (B) A phylogenetic tree of representative species included in the analysis of the evolution of
human TK circuit evolution. They were classified into three groups. (1) The primitive group, including
S. cerevisiae, M. brevicollis, and N. vectensis, represents organisms branched from the human lineage before
the emergence of bilaterians. (2) Ecdyosozoans, including C. elegans and D. melanogaster, represent
organisms between the branches of primitive organisms and vertebrates. (3) Vertebrates that contain
the vertebrate animals we analyzed in this study, representing different branches of vertebrate evolution. The human ancestry line is shown in red. Based on this grouping, we defined origins of human
protein orthologs as follows. If an ortholog is found in a primitive organism, it is assigned a primitive (or
P)-origin. Similarly, if an ortholog is identified in an ecdyosozoan organism but not a primitive organism,
it is considered to have originated from the bilateria (or B-origin). Orthologs found only in vertebrates
are assigned a V-origin. The branch times were estimated based on data from the TimeTree server
(Hedges et al. 2006).
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a circuit may be a transmembrane receptor tyrosine kinase (RTK)
One approach that was used to investigate the evolutionary
or a cytoplasmic tyrosine kinase (CTK), whereas a substrate may
origin of human pTyr signaling utilized a comparison between the
be a membranous or cytoplasmic protein. The SH2/PTB domain–
human TK circuits and the orthologous circuits in each selected
containing proteins were not considered in the signaling route
species. However, some species contain only a small number of
classification because they are primarily cytoplasmic; however,
circuits that are orthologous to the 583 curated circuits, which
notable exceptions can shuttle between the cytoplasm and the
makes it impossible to perform a statistically meaningful analysis
nucleus (e.g., the STAT SH2 domains) (Croker et al. 2008) or beon the evolution of human TK circuits on a per-species basis. To
come membrane-associated (e.g., PI3K). The CTK-cytoplasmic and
overcome this limitation, we classified the selected species into
CTK-membranous signaling routes process signals from a cytoplasthree groups that were based on previous studies that showed the
mic TK to a cytoplasmic or membranous substrate, respectively. In
statistical robustness of this scheme of species classification (Fig.
contrast, the RTK-cytoplasmic and RTK-membranous signaling
1B; Putnam et al. 2007; King et al. 2008). We classified the species
routes transmit signals from a receptor TK to a cytoplasmic or
into primitive, bilaterian, and vertebrate groups. The primitive
membranous substrate, respectively.
group includes S. cerevisiae, M. brevicollis, and N. vectensis. The
bilaterian lineage is represented by the
ecdysozoa, C. elegans, and D. melanogaster.
All of the vertebrate species are placed in
the same group. These three groups correlate grossly with the degree of organismal complexity, which is measured by the
number of cell types. Specifically, primitive organisms contain one or a few cell
types, bilateria contain 20–70 cell types,
and vertebrates are the most complex and
contain more than 100 cell types (Vogel
and Chothia 2006).
Based on this grouping scheme, we
defined the origins of human protein
orthologs as follows. If an ortholog is
identified in an organism of the primitive
group, we define the protein as a primitive (or P)-origin ortholog. If an ortholog
is identified in a bilaterian organism but
not in a primitive organism, it is assigned
to a bilaterian (or B) origin. If an ortholog
is identified only in a vertebrate, it is
assigned to a vertebrate (or V) origin. We
also assigned an evolutionary origin to
each human TK circuit based on the earliest period in which all three components
of the circuit co-existed. For example, the
SRC-CD19(pTyr500)-PIK3R1 circuit (i.e.,
written in the order of writer-substratereader) is considered to have originated
from vertebrates because the circuit was
not complete until a CD19 ortholog appeared in the vertebrate B. taurus, despite the presence of SRC and PIK3R1
orthologs in M. brevicollis (a primitive Figure 2. Evolutionary origins of tyrosine kinase (TK) circuits and signaling routes. (A) A diagram
organism).
depicting the signaling routes for intracellular, inter- or extracellular, and tissue-specific communication

Different signaling routes underlie
intracellular, inter-/extracellular,
and tissue-specific pTyr signaling
To examine the role of the kinases and
substrates in the evolution of the signaling circuitry, the TK circuits were classified into four signaling routes based on
the subcellular localization patterns of
the components, which have been annotated in the Swiss-Prot database (Fig.
2A; Boeckmann et al. 2003). A TK in

1224

Genome Research
www.genome.org

via the TK circuits. A kinase or substrate may be a membranous or cytoplasmic protein. Depending on
cellular locations of its components, a TK circuit may belong to one of the four signaling routes, namely,
RTK-M, RTK-C, CTK-M, and CTK-C, where M and C denote membrane and cytoplasm, respectively. (B)
Enrichment of different signaling routes at distinct evolutionary stages. TK circuits were divided into
‘‘evo-groups’’ according to the origins of the corresponding circuit components. The evo-group is used
to assign the origin of a signaling route. The enrichment of a particular evo-group circuit in a signaling
route provides information on the evolutionary origin of the latter. TK circuits of a particular origin that
are enriched (P < 0.05) in a signaling route for both curated and predicted data sets were identified by
gray rectangles with the significantly enriched evo-group identified by asterisks. Intracellular signaling
(represented by the CTK-C signaling route) is significantly enriched with the PPP evo-group circuits (via
the P-origin self-wiring path). Extracellular or intercellular signaling (represented by the RTK-C route) is
significantly enriched with the BPP evo-group circuits in which newly evolved (B-origin) TKs ‘‘wire back’’
to ancient (P-origin) substrates (via the B-origin RTK-back-wiring path). In contrast, tissue-specific CTK-M
signaling is enriched with PVP circuits that feature vertebrate-origin substrate wiring-back to ancient
(P-origin) TKs and SH2 domain-containing proteins (via the V-origin substrate-back-wiring path). (*) P <
0.05; (***) P < 0.001, randomization test.

Human phosphotyrosine signaling network evolution
This signaling route classification scheme was used to segregate the pTyr circuits into pathways that are associated with intracellular (e.g., CTK-cytoplasmic) or extra-/intercellular signaling
(e.g., RTK-membranous, RTK-cytoplasmic, and CTK-membranous).
The CTK-cytoplasmic route, which accounts for 28.6% of the curated and 34.3% of the predicted circuits, is dedicated to intracellular
signaling through the phosphorylation of cytoplasmic substrates
by a cytoplasmic TK. A CTK may also phosphorylate a membrane
substrate when it is activated by neighboring cells or environmental
cues as in the CTK-membranous route, which accounts for 27.1%
of the curated and 7.9% of the predicted circuits. A typical example
of this signaling route is the phosphorylation of CD247 by FYN in
the T-cell receptor (TCR) signaling pathway (Weiss and Littman
1994). In contrast, membrane-embedded RTKs couple extracellular stimuli to intracellular signaling cascades via the phosphorylation of either cytoplasmic (via the RTK-cytoplasmic route, which
comprises 29.3% of the curated and 45.6% of the predicted circuits) or membranous substrates (via the RTK-membranous route,
which comprises 14.9% of the curated and 12.2% of the predicted
circuits). The RTK-membranous route includes RTK autophosphorylation in which the TK and substrate are located on the same
protein (Deribe et al. 2010; Lemmon and Schlessinger 2010). We
found that 82.8% of the curated RTK-membranous circuits belong
to the RTK autophosphorylation category; this finding probably
reflects a bias of the available experimental data on RTK signaling
(Lemmon and Schlessinger 2010). However, RTK autophosphorylation comprises only 0.03% of the predicted RTK-membranous
circuits. Due to this discrepancy between the curated and predicted
TK circuit data sets, we excluded the RTK-membranous signaling
routes from further analyses.
Signal transduction in vertebrates occurs in a cell- or tissuespecific manner. To determine which signaling route is tissuespecific, we assigned each component of a TK circuit as either
ubiquitously or tissue-specifically expressed, based on the Human
Protein Atlas database (Berglund et al. 2008b). Because most TKs
and SH2/PTB domain–containing proteins (over 92%) are ubiquitously expressed (see Supplemental Data File 3), we assigned tissuespecificity to a TK circuit based on the tissue-specificity of the
corresponding substrate and then examined the tissue-specificity
of the different signaling routes. Approximately 62.8% of the CTKmembranous circuits in the curated database are tissue-specific,
while only 1.2% of the RTK-cytoplasmic and 20.1% of the CTKcytoplasmic circuits are tissue-specific. A similar trend was observed
for the predicted data set; 27.3% of the CTK-membranous circuits
are tissue-specific, while 8.0% of the RTK-cytoplasmic and 7.6% of
the CTK-cytoplasmic circuits are tissue-specific (Table 1). We show
that tissue-specific circuits are significantly enriched in the CTKmembranous route (both Pp and Pc < 1.0 3 10 4, where Pc and
Pp represent the P-values that were obtained from randomization
tests using the curated and predicted TK data sets, respectively).
These results strongly suggest that TK circuits that belong to the
CTK-membranous route are preferentially used in tissue-specific
pTyr signaling.
Because a membrane protein is the substrate of the CTKmembranous circuit, we next examined whether specific membrane proteins are favored for tissue-specific pTyr signaling.
Indeed, we found that >50% of the substrates in either the curated
or the predicted CTK-membranous circuits are receptors, and of
these, only a small fraction are RTKs according to Gene Ontology
(Dennis et al. 2003). This result suggests that CTKs may regulate
nonkinase receptor signaling events by pathway crosstalk. For
example, the direct phosphorylation of an ionotropic glutamate

Table 1.

Tissue-specific TK circuits in different signaling routes
Signaling route
RTK-C

Curated data set
Tissue-specific circuits
Total circuits
Percentage of
tissue-specific circuits
Predicted data set
Tissue-specific circuits
Total circuits
Percentage of
tissue-specific circuits

CTK-M

2
167
1.2%

76
121
62.8% (P < 1.0 3 10

1,562
19,548
8.0%

938
3,436
27.3% (P < 1.0 3 10

CTK-C

4 a

)

4 a

)

33
164
20.1%
1,126
14,816
7.6%

RTK-C indicates RTK-cytoplasmic; CTK-M, CTK-membranous; and CTK-C,
CTK-cytoplasmic.
The P-values obtained from the randomization test. All of the TKs, SH2,
and PTB protein families are widely expressed across all tissues, but a fraction
(i.e., f%) of the substrate families are expressed in a tissue-specific manner.
To test if CTK-M circuits are enriched with tissue-specific circuits, we randomly assigned f% of the total substrates as tissue-specific and then calculated the fraction (f%-random) of the CTK-M circuits that are tissue-specific.
We tested the null hypothesis, f%-random $ f%-real (the fraction of tissuespecific CTK-M circuits in the original data set). Ten thousand times of
randomizations were used for calculating the P-value. The same procedure
was applied to test the tissue-specificity of other types of circuits.
a

receptor by the SRC or FYN kinase regulates its localization and
activity, thereby modulating excitatory neurotransmission in the
brain (Dingledine et al. 1999). Therefore, in addition to being largely
responsible for tissue-specific pTyr signaling, the CTK-membranous
circuits play an important role in regulating signaling pathways that
are mediated by nonkinase membrane receptors.

Distinct evolutionary paths for the intracellular,
inter-/extracellular, and tissue-specific human
pTyr signaling circuits
What are the evolutionary origins and trajectories of the different
signaling routes? To address this question, we examined whether
the human TK circuits that belong to a given signaling route are
statistically enriched at a specific period of evolution by performing randomization tests (see Methods). These analyses indicate
that the CTK-cytoplasmic signaling route is significantly enriched
with primitive-origin circuits (Pc < 1.0 3 10 4; Pp = 2.3 3 10 2)
(Fig. 2B; Supplemental Fig. S2). In contrast, the RTK-cytoplasmic
signaling route is enriched with bilateria-origin circuits (Pc = 9.4 3
10 3; Pp = 1.5 3 10 2) (Fig. 2B; Supplemental Fig. S2). The majority
of tissue-specific CTK-membranous circuits are found in vertebrates,
although this enrichment is not statistically significant (Fig. 2B;
Supplemental Fig. S2). Therefore, human TK circuits for intracellular
pTyr signaling originated mainly from primitive organisms, whereas
those for inter-/extracellular pTyr signaling originated mainly from
the bilaterian lineage.
Although the above analysis identified the evolutionary origins of the CTK-cytoplasmic and RTK-cytoplasmic signaling
routes, it did not provide information of the evolutionary method
of the corresponding TK circuits. To address this question, the TK
circuits were divided into different evolutionary groups, or evogroups, according to the origins of the circuit components. Specifically, an evo-group is represented by a three-letter acronym in
which the three letters denote the origins (i.e., P, B, and V) of the
TK, the substrate, and the SH2/PTB domain of the TK circuit, respectively. For example, a BVP evo-group features a TK of bilaterian
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origin, a substrate of vertebrate origin, and an SH2/PTB domain of
primitive origin (Fig. 2B; Supplemental Fig. S2). It should be emphasized that the evo-groups and the signaling routes are different
methods that can be used to represent the same TK circuits. While
the former method emphasizes the evolutionary origin, the latter
stresses the function of the circuit.
Each component of a TK circuit has three possible evolutionary
origins based on our species grouping scheme (Fig. 1B); therefore,
by enumeration, there are 27 possible evo-groups (i.e., PPP, PBP
and VVV) that can be used to segregate the human TK circuits. We
next examined which evo-group circuits were preferentially used
in a given signaling route by performing randomization tests for
both the curated and predicted circuit data sets (see Methods). The
CTK-cytoplasmic, RTK-cytoplasmic, and CTK-membranous signaling routes are significantly enriched with TK circuits that belong to distinct PPP, BPP, and PVP evo-groups, respectively (Fig. 2B;
Supplemental Fig. S2). Of note, the PPP circuits are significantly
enriched in the CTK-cytoplasmic signaling route (Pc < 1.0 3 10 4;
Pp < 2.3 3 10 2, randomization tests). This indicates that functional coupling among primitive-origin TK components (or the
‘‘self-wiring’’ of components that emerged during the same evolutionary period) is the preferred evolutionary path for intracellular pTyr signaling. However, PPP circuits were also found in
other signaling routes, which suggests that the prototypes of the
human pTyr signaling machineries developed at the earliest stage
of metazoan evolution. In contrast to the role of PPP circuits in
pTyr signaling, BPP circuits are found to be statistically enriched in
the RTK-cytoplasmic signaling route (Pc < 1.6 3 10 3; Pc < 1.7 3
10 2; randomization tests). This finding elucidates an evolutionary path for inter-/extracellular pTyr signaling in which bilaterian
RTKs ‘‘wire back’’ to and phosphorylate ancient substrates (i.e.,
B-origin RTK-back-wiring) (Fig. 2B). These results are consistent
with our findings that the human intracellular pTyr signaling
originated mainly in primitive species, and inter-/extracellular
signaling emerged largely in the bilaterian lineage.
Circuits of the evo-group PVP are significantly enriched in the
CTK-membranous signaling route (Pc or Pp < 1.0 3 10 4) (Fig. 2B;
Supplemental Fig. S2). Because this route is enriched with tissuespecific circuits (Table 1), a likely evolutionary path for tissuespecific pTyr signaling is through V-origin substrate-back-wiring
(Fig. 2B; Supplemental Fig. S2). Specifically, a newly evolved
(vertebrate-origin) substrate is phosphorylated by an existing
(primitive-origin) tyrosine kinase, which, in turn, is recognized
by a primitive SH2/PTB domain. Therefore, although the vertebrate circuits (i.e., PVP, BVP, and VVV) as a group are not significantly enriched in the CTK-membranous signaling route, the TK
circuits of the PVP evo-group must have played an important role
in the evolution of tissue-specific signaling. The evolutionary
landscape of the TCR signaling pathways provides a typical example of how the TK circuits of the PVP evo-group are used in cellspecific pTyr signaling and the pTyr signaling network expansion
(Supplemental Fig. S3).
To test whether our results regarding the significant enrichment of specific evo-groups in the different signaling routes could
tolerate potential mistakes in protein ortholog identification, we
performed a sensitivity assay that is similar to the assay that was
described by Cui et al. (2006). Assuming a false identification rate
of 20% for orthologs (a highly unlikely scenario) by the Roundup
database, we randomly assigned an evolutionary origin (P, B, or V)
to 20% of the TKs, substrates and SH2/PTB proteins in the curated
and predicted data sets. Next, we repeated the same statistical
analysis and found that the corresponding P-values were <0.05.
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These sensitivity assays demonstrate that the conclusions that we
drew from the circuit analysis are robust and can tolerate potential
errors in the identification of orthologs.
Taken together, our analysis indicates an evolutionary hierarchy for the different pTyr signaling functions; intracellular signaling emerged first in primitive organisms, and this signaling was
followed by the emergence of inter- and extracellular signaling in
bilateria. Tissue specific–signaling evolved mainly in the vertebrates.
As summarized in Figure 2B, the distinct evolutionary paths, ‘‘selfwiring,’’ ‘‘B-origin RTK-back-wiring,’’ and ‘‘V-origin substrate-backwiring,’’ that were used by the CTK-cytoplasmic (intracellular
signaling), RTK-membranous (intercellular signaling), and CTKmembranous (tissue-specific signaling) circuits, respectively, suggest a general mechanism for the evolution of the human pTyr
signaling network; new circuits were formed by the back-wiring of
a newly emerged kinase or substrate to the existing components.
This provides an economic yet efficient means by which to wire
and expand the pTyr signaling network by ‘‘recycling’’ existing
circuit components and bestowing upon them new roles through
the functional coupling to newly evolved kinases or substrates.

The pTyr sites that are associated with multiple TK circuits
are hotspots for cancer signaling
Aberrant pTyr signaling drives many of the fundamental biological
processes that accompany tumor initiation and progression. Indeed, genes that encode all of the human TKs, and most (56.7%) of
the human SH2-containing proteins have been identified as cancerdriving genes in COSMIC, a database of somatically acquired mutations in human cancer (Forbes et al. 2011). Using an integrative
analysis of the human signaling network with tumor genomic data,
we previously showed that tyrosine kinases are significantly enriched in the cancer signaling network (Cui et al. 2007). Therefore,
we wanted to determine whether and how the pTyr signaling network is perturbed in cancer at the TK circuit level.
Recent advances in mass spectrometry have led to the identification of numerous phosphorylation sites, including pTyr sites,
in cancer samples (Moran et al. 2006; Olsen et al. 2006; Nita-Lazar
et al. 2008; Macek et al. 2009; Thingholm et al. 2009; Harsha and
Pandey 2010). The availability of cancer-specific phosphoproteomic data provides a unique opportunity to investigate how TK
circuits are wired in cancer cells. To characterize the role of human
TK circuits in cancer-cell signaling, we extracted the pTyr proteome
data that were determined from 191 lung cancer and 48 normal
lung samples (Rikova et al. 2007). We considered pTyr sites that
were identified in cancer samples but not in normal samples to be
cancer pTyr sites. The predicted circuits were employed to analyze
the relationship between the circuits and cancer pTyr sites because
the curated data set contains only limited annotated pTyr sites that
are insufficient for statistical analysis. Of the 998 cancer pTyr sites
contained in 9635 circuits in the data set (see Supplemental File 4),
34% were found to be detected in two or more tumor samples. We
used a frequency cutoff of two (similar trends were obtained when
the cutoff was set to four or seven) to distinguish between highfrequency cancer (HFC) pTyr sites (i.e., a site is detected in two or
more tumor samples) and low-frequency cancer (LFC) pTyr sites
(i.e., a site is detected in only one tumor sample). By using this
criterion, we identified 341 HFC pTyr sites that were associated
with 4245 TK circuits and 657 LFC pTyr sites that were associated
with 5390 TK circuits.
Are HFC and LFC pTyr sites different in their capacity to form
TK circuits? To address this question, we compared the number of

Human phosphotyrosine signaling network evolution
TK circuits that are mediated by an HFC or a LFC pTyr site/substrate. The average number of circuits (12.4) that are linked to an
HFC pTyr site is significantly larger than those (8.20) that are
linked to a LFC pTyr site (P = 1.53 3$10 8; Wilcoxon rank sum
test). This difference may be attributed to the increased capacity of
an HFC pTyr site to be coupled to more TKs or SH2/PTB domains.
We found that an HFC pTyr site, on average, links to more TK
writers and more SH2/PTB readers than does a LFC pTyr site (the
number of writers per HFC/LFC pTyr site was 3.63/2.73, P = 2.23 3
10 9, and the number of readers per HFC/LFC pTyr site was 3.08/
2.65, P = 2.54 3 10 3; Wilcoxon rank sum test). To extract the
general trend, we divided the cancer pTyr sites into four groups
based on their frequencies of detection, and each group contained
>10% of the total cancer pTyr sites. We then plotted the average
number of TKs, SH2s/PTBs, and TK circuits against the frequency of
detection of a pTyr site in the cancer samples (Fig. 3A). It is apparent that the increasing frequency of the detection of a pTyr site
in the cancer samples correlated with an increasing number of
kinases, SH2/PTB domains, and TK circuits that are connected to
the site. Therefore, promiscuous pTyr sites that are shared by many

TKs, SH2/PTB domains, and circuits are potential ‘‘hotspots’’ for
cancer signaling. Presumably, these highly connected pTyr sites are
used to process a variety of cellular information and are used for
signal exchange and integration.
Because all tyrosine kinases are potentially oncogenic and
because cancer-associated mutations are found in most SH2/PTB
proteins, we reasoned that these proteins may play a key role in the
formation of cancer TK circuits. In addition to the Tyr phosphorylation site(s), a substrate may also contain a kinase and/or an SH2/
PTB domain. This latter type of substrate can function as a writer
and/or reader in other TK circuits; therefore, it has dual or multiple
potential functions. To distinguish between these two types of
substrates, we defined a substrate as a dual-role substrate (or DRS) if
it contains a kinase domain and/or an SH2/PTB domain in addition to the pTyr site. We named a substrate a single-role substrate
(or SRS) if it does not contain a kinase or an SH2/PTB domain. Next,
we examined the distribution of cancer pTyr sites in the two types
of substrates. We found that HFC pTyr sites are significantly
enriched in the DRS relative to the SRS type (50.6% vs. 32.6%, P =
6.78 3 10 3; x2 test). This indicates that DRSs are preferentially
recruited for cancer pTyr signaling. Therefore, cancer cells preferentially target signaling hubs that are nucleated by a DRS; these
cells exploit the additional kinase and/or SH2/PTB domain(s) that
are contained in the DRS and the potential of the corresponding
pTyr sites to mediate the formation of a large number of TK circuits.
The different roles of the DRSs and SRSs in cancer pTyr signaling were further characterized by examining their respective
distribution patterns during the different evolutionary periods (Fig.
3B). To accomplish this characterization, we assigned each cancer
TK circuit an evolutionary origin (i.e., primitive, bilateria, or vertebrate) and calculated the number of corresponding DRS- or SRScontaining circuits. We found that TK circuits that originated in all
three of the origins are statistically enriched with DRSs that harbor
HFC pTyr sites compared with the SRSs (P = 0.029, 0.027, and 0.047
for the primitive, bilaterian, and vertebrate groups, respectively; x2
test). Therefore, cancer pTyr signaling selectively recruits DRSs regardless of evolution.
Taken together, our data show that cancer signaling preferentially employs pTyr sites that are coupled to more TK circuits and
those that contain DRSs.

Discussion

Figure 3. Cancer TK circuits preferably make use of multifunctional
substrates and highly connected pTyr sites. (A) Cancer TK circuits are
highly connected. Shown in the graph is a correlation between the frequency of a pTyr site to be detected from cancer samples (x-axis) and the
number of SH2/PTB domains, TKs, or circuits connected to that site, based
on the predicted data set. The cancer pTyr sites are divided into five groups
(based on frequency of detection) to ensure that each group has at least
10% of the total cancer pTyr sites. (B) TK circuits identified with high
frequency in cancer samples are significantly enriched in multifunctional
substrates of the primitive (P), bilaterian (B), and vertebrate (V) origin. The
substrates corresponding to the high-frequency cancer (HFC) pTyr sites
are divided into either the SRS (singular-role substrate) or the DRS (dualrole substrate) group according to the absence or presence of a kinase
and/or an SH2/PTB domain in the same substrate. Bar graph: comparison
in the number (shown in percentage) of HFC pTyr sites in the SRS and DRS
groups. The substrates are classified according to their evolutionary origins.
DRSs of the P-, B-, and V-origin are significantly enriched in cancer signaling.
P-values were calculated using x2 test.

In this study, we used a network approach to examine the evolutionary history of the human pTyr signaling. We deconvoluted
the pTyr network into basic functional units, or TK circuits. Our
analysis revealed that intracellular, intercellular, and tissue-specific
pTyr signaling routes possessed distinct evolutionary origins, evolved
in a stepwise manner, and, furthermore, took distinct evolutionary
paths that produced the different pTyr signaling functions.
Intracellular signaling first appeared in primitive metazoans
by ‘‘self-wiring’’ (Fig. 2B), which implies that the circuit components, including CTKs, substrates, and SH2/PTB domains, were
intact in the selected primitive species; these components were
probably also present in the common ancestors of these primitive
species. It is intuitively plausible that intracellular pTyr signaling
was the first to emerge in metazoan evolution because the ancestral
species either are unicellular or contain a few cell types; therefore,
the need for extracellular signaling and intercellular communication is not as urgent as in more complex metazoans. This hypothesis
is consistent with the finding that extra-/intercellular pTyr signaling
is statistically enriched with TK circuits that evolved in the bilaterian
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lineage. An inter- and extracellular signaling circuit features a
bilateria-origin kinase that phosphorylates a primitive substrate,
which, in turn, recruits a primitive protein that contains an SH2/
PTB domain. This type of evolutionary pathway, which is termed
B-origin RTK-back-wiring (Fig. 2B), is apparently used to expand the
human pTyr signaling network for inter- and extracellular communication in bilaterian animals (e.g., Ecdysozoa) and their immediate ancestors.
In contrast, tissue-specific pTyr signaling is characterized by
the presence of additional circuits that first emerged in the vertebrate lineage. Intriguingly, we found that tissue-specific signaling
circuits are formed via the phosphorylation of a vertebrate-origin
substrate by a primitive tyrosine kinase, which is followed by the
recruitment of a primitive SH2/PTB domain (V-origin substrateback-wiring path) (Fig. 2B). Therefore, instead of reinventing the
toolkit of pTyr signaling, new circuits formed in the late stages of
metazoan evolution, which exploited pre-existing circuit components by coupling them to newly evolved substrates. This mechanism of the pTyr signaling network expansion is highly economical and is an effective means of engendering novel signaling
functions to an ancient regulatory protein.
It is noteworthy that these conclusions are drawn from the
statistical analysis of circuit enrichment for a particular signaling
function, which does not imply the absence of any circuit for tissue-specific or intercellular communication in a primitive organism. On the contrary, all three types of circuits can be found in at
least one target species of the primitive group, which suggests that
the prototypes of pTyr signaling were developed at the earliest
stage of metazoan evolution when the toolkit was in place. It
should be noted that our observations are based on the current
genome sequences of a number of organisms that originated either
before or after the emergence of metazoans from single-celled
eukaryotic ancestors. When more genome sequences and more
experimentally determined TK circuits become available in the
future, it would be interesting to confirm and expand on these
observations. Although our analysis is based on 19 representative
species, we expect the main conclusions of the current work to
stand the test of time. In support of this assertion, we added nine
Primitive-stage species in the analysis and found that the enrichment patterns of TK circuits (Fig. 2B) were not changed . Therefore,
the models we present here should provide a useful framework for
the determination of the origins of pTyr signaling and the origins
of analogous multicomponent signaling platforms (circuits).
We also provide a system-level understanding of pTyr signaling
in cancer. We showed that the pTyr sites that are linked to multiple
kinases, SH2/PTB domains, and TK circuits form hotspots for cancer
cell signaling. Previous studies suggest that hub kinases are preferentially involved in cancer signaling (Miller et al. 2008, Tan et al.
2009a). Taken together, these subnetworks that are defined by
kinase hubs and pTyr site hubs are preferentially used by cancer
signaling. Therefore, targeting these subnetworks may provide an
effective strategy for cancer intervention (Olsen et al. 2006).
In summary, our study provides insights into the evolution of
the human pTyr signaling network, and the implications of this
study will impact the understanding of normal cellular functions
and the mechanism of tumorigenesis.

Methods
Definition of TK circuits
We defined a TK circuit as a three-component system composed of
(1) a TK that functions as a writer to add a phosphate moiety to
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a Tyr residue, (2) a substrate that contains the Tyr residue that is
phosphorylated by the TK, and (3) a protein containing an SH2 or
PTB domain that functions as the reader of the pTyr residue. Since
the pTyr on a substrate is necessary for the TK circuit to be functional, only experimentally verified pTyr sites were used to build
the collection of human TK circuits analyzed herein.

Construction of a curated human TK circuit data set
We manually collected the experimentally determined human TK–
substrate interactions and substrate–SH2/PTB domain interactions
from the literature (see Supplemental Materials), as well as the
Phospho.ELM and PhosphoSitePlus databases (Diella et al. 2004;
Hornbeck et al. 2004). We grouped the closely related proteins
(e.g., CRK and CRKL) into families because they have similar
binding properties and biological functions (Huang et al. 2008).
The TK and SH2 protein families were identified based on the
Kinome database and the relevant literature (Enright et al. 2002;
Boeckmann et al. 2003; Huang et al. 2008). The substrate families
were identified based on the Ensembl family database (Enright
et al. 2002). Once a pTyr site was identified in one member of
a protein family, the corresponding site in other members of the
same family were identified by sequence alignment using the
program MAFFT (version 6.846, E-INS-i option with default parameters) (Katoh et al. 2005). For example, Tyr221 in CRK aligns
with Y207 in CRKL, and both have been shown to be phosphorylated (Hornbeck et al. 2004). We treated these two pTyr sites as
a single pTyr site because it is highly probable that they are phosphorylated by the same kinase(s) and read by the same SH2/PTB
domain(s) and thereby have similar functions in the signaling
network. If a TK–substrate and a substrate–SH2/PTB interaction
involve the same pTyr site, they are integrated into a TK circuit. All
three components in ;80% of the curated TK circuits are experimentally verified, whereas either the TK or the SH2/PTB domain is
missing from the remaining circuits. In the latter case, we completed the circuits by using appropriate bioinformatic pipelines to
predict the corresponding tyrosine kinases or SH2/PTB domains,
respectively. TKs were predicted using NetworKIN and NetPhorest
(Linding et al. 2007; Miller et al. 2008). The kinase identified by
both programs was considered as the writer for the pTyr site.
Similarly, we predicted the SH2 reader using NetPhorest and SMALI
(Li et al. 2008; Miller et al. 2008) and predicted the PTB readers
using NetPhorest (Miller et al. 2008). The predicted writers and
readers were then integrated with the substrate containing the
pTyr to construct the TK circuits. Approximately 20% of the TK
circuits were constructed in this manner.
The curated data set contains 583 circuits covering 20 of 29 TK
families, 26 of 38 SH2 families, six PTB families, and 92 substrate
families bearing 243 pTyr sites in humans. It should be noted that
the number of pTyr sites did not exactly match the number of TK
circuits. For instance, Tyr72 in the protein BLNK could be phosphorylated by either SYK or INSR (insulin receptor) and bind to
either the VAV or GRB2 SH2 domains upon phosphorylation.
Therefore, this pTyr site in BLNK is involved in four TK circuits.

Computationally predicted human TK circuits
To increase coverage of the pTyr signaling network, we constructed
a data set comprising over 50,000 computationally predicted human TK circuits. Each of the predicted circuits contains an experimentally determined pTyr site as annotated in the PhosphoSitePlus
database (Hornbeck et al. 2004), a TK predicted to phosphorylate
this site, and an SH2 or a PTB domain predicted to bind to the pTyr.
For each pTyr site, its TK writers were predicted using NetPhorest
and GPS2.1 with a high threshold of false-positive rate 2% (Xue et al.
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2008). If a TK was covered by both programs, the TK writers predicted by both methods were retained. If the TK was covered by
a single program, this program was employed for the prediction.
The SH2 readers were predicted by both NetPhorest and SMALI (Li
et al. 2008; Miller et al. 2008), and the PTB readers were predicted by
NetPhorest. The pTyr sites that have predicted writers and readers
were retained in the data set. Protein families were constructed as
described above. The aligned pTyr sites from different members
within a substrate family were considered as a single pTyr site if they
share at least one predicted TK writers and at least one SH2/PTB
readers. Otherwise, the aligned pTyr sites were considered as different pTyr sites since they have dissimilar specificity, suggesting
that they have different functions. A circuit was constructed by
integrating a single pTyr site, a single writer, and a single reader.
Finally, using the computational approach we constructed 50,475
circuits, in which half of the curated circuits are included.

Assignment of evolutionary origins of the human TK circuits
We assigned the evolutionary origins of the human TK circuits
based on the orthologous circuits in 19 eukaryotes mentioned above
(Fig. 1B). For each human TK circuit, we used the Roundup database
(Wall et al. 2003) to identify orthologs of the circuit components
in these selected species. We next classified these organisms into
three different evolutionary periods (P, B, and V; see main text). We
then annotated the evolutionary origins of the three components
(i.e., TKs, substrates, and SH2s/PTBs) of each human TK circuit.
The evolutionary period in which a component first appeared was
considered the origin of the corresponding protein or protein family. For instance, if a TK (e.g., ABL) was found from M. brevicollis to
H. sapiens, it is considered to be originated in the primitive period.
Finally, the origin of a circuit was assigned to the evolutionary period in which the last circuit component appeared. For example, in
the circuit SRC(TK)/CD19(substrate, pTyr500)/ PIK3R1(SH2), the
orthologs of the human SRC and PIK3R1 were found in M. brevicollis
(a primitive organism), but the ortholog of the human CD19 was
first seen in B. taurus (a vertebrate). This circuit was assigned a vertebrate (or V) origin. The evolutionary annotations of the circuits are
documented in Supplemental Data Files 1 and 2. In an independent
analysis, we used the InParanoid database (Berglund et al. 2008a) for
ortholog identification, repeated the same circuit analyses as described in the main text, and obtained similar results (data not
shown). It should be noted that both human tyrosine kinases and
SH2 domain–containing proteins include multiple domains, some
of which are well co-conserved with TK and SH2 domains, respectively (Pincus et al. 2008). We employed this feature to determine the orthologs of tyrosine kinases and SH2 proteins. A
protein was defined as the ortholog of a query tyrosine kinase/SH2
domain–containing protein that not only was identified by the
ortholog database but also contained at least one same domain
plus TK/SH2 domain as the query protein.

tissue-specific proteins are those expressed in 20 tissues (data not
shown).

Statistical analysis
Fisher’s exact tests, x2 tests, Wilcoxon rank-sum tests, and randomization tests were used to evaluate the statistical significance
of our observations. The detailed procedures for network circuit
randomization tests have been described previously (Wang and
Purisima 2005). For the randomization test of the tissue-specific
circuits, we use CTK-membranous as an example. To test if CTKmembranous circuits are enriched with tissue-specific circuits, we
randomly assigned f% of the total substrates as tissue-specific and
then calculated the fraction (f%-random) of the CTK-membranous
circuits that are tissue-specific. We tested the null hypothesis, f%random $ f%-real (the fraction of tissue-specific CTK-membranous
circuits in the original data set). Ten thousand times of randomizations were used for calculating the P-value. The same procedure
was applied to test the tissue-specificity of other types of circuits.
To perform randomization tests for the TK circuits, we built a network using the curated TK circuits (for testing in the curated data
set) or the predicted TK circuits (for testing in the predicted data
set) and then randomly swapped the evolutionary origins (P, B, and
V) to the circuit components.
To test the enrichment of a signaling route in an evolutionary
stage or period, for each round of the randomly shuffling of the
evolutionary origins (P, B, and V) of the circuit components, we tested
the null hypothesis, EN $ RN, where EN and RN are the expected and
the real numbers of the circuits for the signaling route in that evolutionary period, respectively. The P-values were calculated based on
10,000 times of randomizations.
To test the enrichment of an evo-group in a signaling route,
we applied the same randomization testing procedures, but tested
the null hypothesis, EN $ RN, where EN and RN are the expected
and the real numbers of the evo-group circuits in that signaling
route, respectively.
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Determination of the tissue specificity of the TK circuits
We annotated the expression of each circuit component as tissuespecific or ubiquitous (widely expressed) based on the Human
Protein Atlas (Berglund et al. 2008b), which documents the expression patterns of human proteins in ;65 (64–66) different tissues/cell types. If a protein is expressed in more than half of the
tissues/cells (33), we consider it as a ubiquitous protein; otherwise,
we consider it as a tissue-specific protein. We considered a protein
family as ubiquitous if it contains at least one ubiquitous protein.
Otherwise, the family was annotated as tissue-specific. Our observation that CTK-membranous circuits are enriched in tissue-specific
proteins is still correct when other thresholds are employed, such as
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